Could a vaginal probiotic replace antibiotics for recurrent UTIs?

NCT ID NCT07186465

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compares two ways to prevent repeat urinary tract infections (UTIs) in women after menopause. One group takes a nightly antibiotic pill for 6 months, while the other uses a vaginal tablet containing a probiotic (Lactobacillus) and a tiny amount of estrogen. The goal is to see which approach better prevents infections and how they affect the urinary microbiome. About 100 women will participate for 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nitrofurantoin (antibiotic) and Gynoflor (vaginal tablet containing Lactobacillus with ultra-low-dose estriol)
What this could lead to
If it works, this could point toward a non-antibiotic option to prevent recurrent UTIs in postmenopausal women, reducing antibiotic use and resistance.
What could go wrong
This is a small pilot study (100 participants) and may not provide definitive answers. The probiotic approach may be less effective than antibiotics, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTITIS RECURRENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of Medicine Ramathibodi Hospital Mahidol University

    RECRUITING

    Bangkok, Phayatai Ratchathewi, 10400, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.